The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study

오형중,이혜아,문창모,류동열 연세대학교의과대학 2020 Yonsei medical journal Vol.61 No.6

Purpose: Although both chronic kidney disease (CKD) and diabetes mellitus (DM) are considered factors increasing the risk of colorectal cancer (CRC), their impact on CRC is not fully understood. This study was aimed to investigate the impact of CKD, DM, or both diseases on the risk of CRC and to evaluate sex differences therein. Materials and Methods: Using data from the National Health Insurance Service–Health Examination Cohort in Korea, we conducted a 1:2 matched case-control study. The disease groups consisted of CKD-/DM+ (n=17700), CKD+/DM- (n=22643), and CKD+/DM+ groups (n=8506). After 1:2 matching by age, sex, and health examination year and month, the healthy control group consisted of 97698 individuals. Results: Multivariate Cox regression analysis showed that the CKD-/DM+, CKD+/DM-, and CKD+/DM+ groups were independently associated with an increased incidence of CRC, compared with controls [hazard ratio (HR), 1.34, 1.31, and 1.63, respectively; all p<0.001]. Compared to the controls, adjusted HRs for the cumulative incidence of CRC in the CKD-/DM+, CKD+/DM-, and CKD+/DM+ groups were, respectively, 1.32, 1.26, and 1.43 in male and 1.38, 1.39, and 2.00 in female. The HR for CRC incidence was significantly higher for the CKD+/DM+ group than for the CKD-/DM+ or CKD+/DM- group in female; however, this significant difference was not observed in male. Conclusion: In female, having both CKD and DM significantly increases the risk of CRC, compared with having CKD or DM alone. This study suggests a significant difference in the effect of CKD or DM on the risk of CRC according to sex.

Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Large Cell Neuroendocrine Carcinoma

오형중,강신욱,이미정,장선정,신동호,박희명 연세대학교의과대학 2012 Yonsei medical journal Vol.53 No.3

The syndrome of inappropriate antidiuretic hormone secretion has only been reported in a few patients with large cell neuroendocrine carcinoma (LCNEC); however, it has never been reported in a patient with LCNEC of the lung, whose serum sodium levels were normalized after surgical resection of the mass. A 63-year-old male presented with a two-day history of dizziness and recent memory loss. On admission,his serum sodium level was 113 mEq/L with a serum osmolality of 236 mosm/kg, a urine osmolality of 441 mosm/kg, and a urine sodium level of 65 mEq/L. His chest computed tomography revealed a 2.7×2.3 cm-sized mass in the left lower lobe. After surgical removal of the mass, his serum sodium concentrations were normalized, and histopathology of the mass revealed LCNEC.

투석을 시행 받고 있는 말기 신부전증 환자에서 위장관 출혈의 위험인자

오형중 ( Hyung Jung Oh ),김승준 ( Seung Jun Kim ),박선영 ( Sun Young Park ),유동은 ( Dong Eun Yoo ),이한성 ( Han Sung Lee ),구남수 ( Nam Su Ku ),문지애 ( Ji Ae Moon ),김동기 ( Dong Ki Kim ),이태희 ( Tae Hee Lee ),문성진 ( Sung Jin 대한내과학회 2007 대한내과학회지 Vol.72 No.6

목적: 말기 신부전증 환자에서 전체 사망 중 3~7%는 상부 위장관 출혈과 연관되어 있는 것으로 알려져 있다. 그러나 말기 신부전증 환자에서 위장관 출혈이 호발하는 이유 및 위험인자에 대한 국외 종종 있었으나 이에 대한 국내 보고는 전무한 실정이다. 이에 저자들은 투석을 시행 받고 있는 말기 신부전증 환자에서 위장관 출혈의 임상상 및 위험인자를 알아보고자 하였다. 방법: 2000년 1월부터 2005년 12월까지 연세대학교 의과대학 부속 세브란스 병원에서 위장관 출혈이 발생하였던 말기 신부전증 환자 65명(환자군)과 연령, 성별 그리고 투석 방법이 대응되는 위장관 출혈이 없었던 말기 신부전증 환자 65명(대조군)을 대상으로 위장관 출혈의 임상상 및 독립적 위험인자를 분석하였다. 결과: 심부전증(40.0% vs. 21.5%, p<0.05), 관상동맥 질환(32.3% vs. 4.6%, p<0.005) 그리고 비스테로이드성 소염제 복용력(18.4% vs. 1.5%, p<0.01) 모두 위장관 출혈 환자군에서 의미있게 많았다. 반면에 혈청 알부민 농도는 환자군에서 대조군에 비하여 통계학적으로 의의있게 낮았다(2.53±0.67 g/dL vs. 3.56±0.63 g/dL, p<0.005). 다변량 분석상 관상동맥 질환, 비스테로이드성 소염제, 그리고 혈 알부민 수치가 위장관 출혈의 독립적 위험인자로 나타났으며, odds ratio는 각각 23.0, 12.5, 2.9이었다. 결론: 말기 신부전증 환자에서 관상동맥 질환 동반시 위장관 출혈 발생에 대한 세심한 관찰이 필요하겠으며, 출혈의 예방적 차원에서 비스테로이드성 소염제 사용에 특별한 주의가 필요할 것으로 생각된다. 또한 영양상태의 유지 및 관리도 중요할 것으로 사료된다. Background: Gastrointestinal bleeding (GIB) is not a rare complication in end stage renal disease (ESRD) patients on dialysis and the occurrence of GIB has also been associated with higher morbidity and mortality rates. However, reasons for the high incidence of GIB are not clear. This retrospective study was undertaken not only to analyze the clinical features of GIB but also to elucidate the independent risk factors for GIB in Korean ESRD patients. Methods: One hundred thirty ESRD patients on dialysis at the Severance Hospital of Yonsei University College of Medicine from January 2000 to December 2005 were included in the study. The patients were divided into two groups: 65 patients with GIB (the GIB group) and 65 age-, sex-, and dialysis modality-matched patients without GIB (the C group). Clinical characteristics, medications, and laboratory findings were compared between the two groups. Results: Compared to the C group, congestive heart failure (40.0% vs. 21.5%, p<0.05), coronary arterial occlusive disease (CAOD) (32.3% vs. 4.6%, p<0.005), and nonsteroidal anti-inflammatory drug (NSAID) use (18.4% vs. 1.5%, p<0.01) were significantly more common in the GIB group. The baseline serum albumin levels were significantly lower in the GIB group than in the C group (2.53±0.67 g/dL vs. 3.56±0.63 g/dL, p<0.005). Using logistic regression analysis, CAOD (OR=23.0), NSAID use (OR=12.5), and lower serum albumin levels (OR=2.9) were identified as independent risk factors for GIB (p<0.05). Conclusions: Careful attention must be paid to ESRD patients with CAOD, taking NSAIDs, or with low serum albumin levels in view of GIB. (Korean J Med 72:616 624, 2007)

갑상선기능저하증에 의한 흉막액

오형중 ( Hyung Joong Oh ),박선영 ( Sun Young Park ),변민광 ( Min Kwang Byun ),정우영 ( Woo Young Chung ),박무석 ( Moo Suk Park ),문진욱 ( Jin Wook Moon ),강신명,한창훈,김영삼 ( Young Sam Kim ),장준 ( Joon Chang ),김성규 ( Sung Kyu K 대한결핵 및 호흡기학회 2005 Tuberculosis and Respiratory Diseases Vol.59 No.3

호중구 감소성 발열을 보인 고형암 환자의 임상양상 및 그람양성균 균혈증의 위험인자

구남수,김준형,최유경,정세진,오형중,윤기태,김연아,신소연,김명수,김영근,박윤선,최준용,송영구,이경원,김준명 대한감염학회 2006 Infection and Chemotherapy Vol.38 No.5

목 적 : 항암요법을 시행받고 호중구 감소성 발열이 발생한 고형암환자에서 임상양상을 분석하고 그람양성균 균혈증의 위험인자를 알아보고자 하였다. 재료 및 방법 : 2002년 1월부터 2004년 12월까지 연세대학교 의과대학 세브란스 병원 종양내과에서 고형암으로 진단받고 항암요법을 시행받은 18세 이상의 암환자에서 호중구 감소성 발열이 있었던 288예를 대상으로 하였다. 결 과 :항암요법을 시행받은 고형암 환자 중 288예에서 호중구 감소성 발열이 발생하였다. 이중 원인을 찾을 수 있었던 경우는 130예로 전체 45.1% 이었으며 미생물학적 확인감염(microbiologically documented infection, MDI)은 53예(18.4%) 이었다. 균혈증이 동반된 호중구 감소성 발열의 원인균 분포를 보면 총 53예에서 그람양성균이 27예 분리되어 50.9%를 차지하였고 그람음성균이 25예(47.2 %), 진균 1예(1.9%) 순이었다. 그람양성균 중에서 methicillin 내성 포도상구균의 비율은 35% 이었다. 호중구 감소성 발열 환자에서 그람양성균 균혈증의 독립적인 위험인자를 분석한 결과 중심정맥 카테터와 연관된 감염이 있는 경우, 구내 점막염이 발생한 경우, 그리고 피부 및 연조직 감염이 발생한 경우에서 그람양성균 균혈증의 위험이 높았다. 결 론 : 호중구 감소성 발열이 발생한 고형암 환자에서 그람양성균 균혈증이 가장 높은 빈도를 보였으며 특히 중심정맥 카테터와 연관된 감염이 있는 경우, 구내 점막염이 발생한 경우, 그리고 피부 및 연조직 감염이 발생한 경우에서 그람양성균 균혈증의 위험이 높음을 알 수 있었다. 따라서 호중구 감소성 발열이 발생한 고형암 환자에서 발열 당시에 위와 같은 위험인자가 있을 경우 glycopeptide의 조기 사용을 고려해야 할 것으로 사료되며 앞으로 더 많은 환자를 대상으로 하는 전향적 연구가 진행되어야 할 것으로 생각된다. Backgrounds : Recently, there has been a rise of prevalence of gram positive infection among cancer patients with febrile neutropenia. The proportion of antibiotic-resistant gram positive infection has been growing lately, especially in Korea, where the rate of MRSA infection was over 70%. It brings to careful consideration of early glycopeptide treatment in febrile neutropenic patients if gram positive infection is suspected. Also until now, most studies concerning febrile neutropenic patients were mainly related to hematologic malignancy rather than solid tumor. Materials and Methods : We evaluated clinical manifestations and risk factors for gram positive bacteremia in a cohort of 288 solid tumor patients who were more than 18 years old and had neutropenic fever after chemotherapy from January 2002 to December 2004 at the Department of Oncology, Yonsei Cancer Center, Seoul. Results : We identified the cause of fever in 130 (45.1%) cases, of which 53 (18.4%) cases were blood stream infection. Gram positive organism was isolated in 27 cases which comprises 50.9% of blood stream infections, followed by gram negative organism (47.2%) and fungus (1.9%). A logistic regression analysis revealed that gram positive bacteremia was associated independently with central venous catheter (CVC) infection, oropharyngeal mucositis, skin and soft tissue infection in febrile neutropenic patients with solid tumor. Conclusions : Gram positive bacteremia was common among febrile neutropenic patients in solid tumor and was associated with CVC infection, oropharyngeal mucositis, skin and soft tissue infection. The early use of glycopeptide must be taken into account in such conditions.

호중구 감소성 발열을 보인 고형암 환자의 임상양상 및 그람양성균 균혈증의 위험인자

구남수,김준형,최유경,정세진,오형중,윤기태,김연아,신소연,김명수,김영근,박윤선,최준용,송영구,이경원,김준명 대한감염학회 2006 감염과 화학요법 Vol.38 No.5

목적 : 항암요법을 시행받고 호중구 감소성 발열이 발생한 고형암환자에서 임상양상을 분석하고 그람양성균균혈증의 위험인자를 알아보고자 하였다. 재료 및 방법 : 2002년 1월부터 2004년 12월까지 연세대학교 의과대학 세브란스 병원 종양내과에서 고형암으로 진단받고 항암요법을 시행받은 18세 이상의 암환자에서 호중구 감소성 발열이 있었던 288예를 대상으로 하였다. 결과 : 항암요법을 시행받은 고형암 환자 중 288예에서 호중구 감소성 발열이 발생하였다. 이중 원인을 찾을 수 있었던 경우는 130예로 전체 45.1% 이었으며 미생물학적 확인감염(microbiologically documented infection, MDI)은 53예(18.4%) 이었다. 균혈증이 동반된 호중구 감소성 발열의 원인균 분포를 보면 총 53예에서 그람양성균이 27예 분리되어 50.9%를 차지하였고 그람음성균이 25예(47.2%), 진균 1예(1.9%) 순이었다. 그람양성균 중에서 methicillin 내성 포도상구균의 비율은 35% 이었다. 호중구 감소성 발열 환자에서 그람양성균 균혈증의 독립적인 위험인자를 분석한 결과 중심정맥 카테터와 연관된 감염이 있는 경우, 구내 점막염이 발생한 경우, 그리고 피부 및 연조직 감염이 발생한 경우에서 그람양성균 균혈증의 위험이 높았다. 결론 : 호중구 감소성 발열이 발생한 고형암 환자에서그람양성균 균혈증이 가장 높은 빈도를 보였으며 특히 중심정맥 카테터와 연관된 감염이 있는 경우, 구내 점막염이 발생한 경우, 그리고 피부 및 연조직 감염이 발생한 경우에서 그람양성균 균혈증의 위험이 높음을 알 수 있었다. 따라서 호중구 감소성 발열이 발생한 고형암 환자에서 발열 당시에 위와 같은 위험인자가 있을 경우 glycopeptide의 조기 사용을 고려해야 할 것으로 사료되며 앞으로 더 많은 환자를 대상으로 하는 전향적 연구가 진행되어야 할 것으로 생각된다. Backgrounds : Recently, there has been a rise of prevalence of gram positive infection among cancer patients with febrile neutropenia. The proportion of antibiotic-resistant gram positive infection has been growing lately, especially in Korea, where the rate of MRSA infection was over 70%. It brings to careful consideration of early glycopeptide treatment in febrile neutropenic patients if gram positive infection is suspected. Also until now, most studies concerning febrile neutropenic patients were mainly related to hematologic malignancy rather than solid tumor. Materials and Methods : We evaluated clinical manifestations and risk factors for gram positive bacteremia in a cohort of 288 solid tumor patients who were more than 18 years old and had neutropenic fever after chemotherapy from January 2002 to December 2004 at the Department of Oncology, Yonsei Cancer Center, Seoul. Results : We identified the cause of fever in 130 (45.1%) cases, of which 53 (18.4%) cases were blood stream infection. Gram positive organism was isolated in 27 cases which comprises 50.9% of blood stream infections, followed by gram negative organism (47.2%) and fungus (1.9%). A logistic regression analysis revealed that gram positive bacteremia was associated independently with central venous catheter (CVC) infection, oropharyngeal mucositis, skin and soft tissue infection in febrile neutropenic patients with solid tumor. Conclusions : Gram positive bacteremia was common among febrile neutropenic patients in solid tumor and was associated with CVC infection, oropharyngeal mucositis, skin and soft tissue infection. The early use of glycopeptide must be taken into account in such conditions.

Rifampicin-Induced Minimal Change Disease Is Improved after Cessation of Rifampicin without Steroid Therapy

박동혁,오형중,이설아,정현주,유태현,강신욱 연세대학교의과대학 2015 Yonsei medical journal Vol.56 No.2

There are several reports to demonstrate that rifampicin, a major anti-tuberculosis agent, is associated with some adverse renal effects, with a few cases of rifampicin-induced minimal change disease (MCD). In the present case, a 68-year-old female presented with nausea, vomiting, foamy urine, general weakness and edema. She had been taking rifampicin for 4 weeks due to pleural tuberculosis. The patient had no proteinuria before the anti-tuberculosis agents were started, but urine tests upon admission showed heavy proteinuria with a 24-h urinary protein of 9.2 g/day, and serum creatinine, albumin, and total cholesterol levels were 1.36 mg/dL, 2.40 g/dL, and 283 mg/dL, respectively. MCD was diagnosed, and the patient achieved completeremission after cessation of rifampicin without undergoing steroid therapy.

말기신부전증 환자에서 심혈관계 질환

박정탁,오형중,강신욱 대한의사협회 2013 대한의사협회지 Vol.56 No.7

The number of end-stage renal disease (ESRD) patients is progressively growing with more than 60,000 ESRD patients on renal replacement therapy in Korea. The mortality risk in ESRD patients is approximately 10 to 20-fold higher compared to the general population, which is mainly attributed to prevalent cardiovascular disease in these patients. However, the risk factors for cardiovascular disease in ESRD patients are different from the general population,and useful biomarkers for predicting cardiovascular mortality are not completely defined. The nationwide multicenter Clinical Research Center (CRC) for ESRD program was initiated in Korea not only to elucidate the incidence and prevalence of cardiovascular disease in ESRD patients but also to identify potential risk factors including various biomarkers for cardiovascular disease. A prospective cohort of 864 incident hemodialysis patients, from 34 dialysis centers of the CRC for ESRD in Korea, was followed up for 36 months, and the clinical outcome of these patients was reviewed. This article presents the recent data from the CRC for ESRD program,and, in addition, brief reviews on key risk factors and potential biomarkers for cardiovascular disease in ESRD patients.

Stepwise Treatment Using Corticosteroids Alone and in Combination with Cyclosporine in Korean Patients with Idiopathic Membranous Nephropathy

신동호,이미정,오형중,구향모,도파미,김형래,한재현,박정탁,한승혁,최규헌,유태현,강신욱 연세대학교의과대학 2013 Yonsei medical journal Vol.54 No.4

Purpose: We undertook an observational study to investigate the effects of immunosuppressive treatment on proteinuria and renal function in 179 Korean idiopathic membranous nephropathy patients with nephrotic syndrome. Materials and Methods:The primary outcome was regarded as the first appearance of remission and the secondary outcomes as a decline in estimated glomerular filtration rate (eGFR) >50% or initiation of dialysis, and all-cause mortality. Seventy-two (40.2%) and 50 (27.9%) patients were treated with corticosteroids alone (C) and corticosteroids plus cyclosporine (C+C), respectively, whereas 57 (31.8%) did not receive immunosuppressants (NTx). Cyclosporine was added if there was no reduction in proteinuria of >50% from baseline by corticosteroids alone within 3 months. Results: There were no differences in baseline renal function and the amount of proteinuria among the three groups. Overall, complete remission (CR) was achieved in 88 (72.1%) patients by immunosuppressants. In a multivariate analysis adjusted for covariates associated with adverse renal outcome, the probability of reaching CR was significantly higher in the C [hazard ratio (HR), 4.09; p<0.001] and C+C groups (HR, 2.57; p=0.003) than in the NTx group. Kaplan-Meier analysis revealed that 5-year CR rates of C, C+C, and NTx groups were 88.5%, 86.2%, and 56.7% (p<0.001). Ten-year event-free rates for the secondary endpoints in these three groups were 91.7%, 79.9%, and 57.2% (p=0.01). Conclusion: Immunosuppressive treatment was effective in inducing remission and preserving renal function in these patients. Therefore, stepwise treatment using corticosteroids alone and in combination with cyclosporine is warranted in these patients.

Effect of Peritoneal Dialysis Modality on the 1-Year Rate of Decline of Residual Renal Function

최규헌,김찬호,오형중,이미정,권영은,김영리,남기헌,박경숙,안성영,고광일,구향모,도파미,한승혁,유태현,김범석,강신욱 연세대학교의과대학 2014 Yonsei medical journal Vol.55 No.1

Purpose: The effect of different peritoneal dialysis (PD) modalities on the decline in residual renal function (RRF) is unclear due to inconsistencies among studies. In particular,the effect of automated peritoneal dialysis (APD) modalities [continuous cyclic peritoneal dialysis (CCPD) and nightly intermittent peritoneal dialysis (NIPD)] on RRF has not been examined in a large cohort. Materials and Methods: We conducted a single-center retrospective study to investigate the association between PD modalities and decline in RRF in 142 incident PD patients [34 on CCPD, 36 on NIPD, and 72 on continuous ambulatory peritoneal dialysis (CAPD)]. RRF was measured within 2 months from PD start and at 1 year after PD initiation. Results: The RRF at 1 year after PD initiation was 1.98±2.20 mL/min/1.73 m² in CCPD patients and 3.63±3.67 mL/min/1.73 m² in NIPD patients, which were moderately lower than 4.23±3.51 mL/min/1.73 m² in CAPD patients (p=0.064). Moreover, there was no significant difference in the 1-year rate of decline of RRF between CCPD and NIPD patients, although APD patients had a faster 1-year RRF decline rate than CAPD patients (CCPD and NIPD vs. CAPD: -45.68 and -36.69 vs. 1.17%/year, p=0.045). APD was associated with a more rapid decline in RRF in patients with end-stage renal disease undergoing PD, although multivariate analysis attenuated the significance of this finding (β=-31.50; 95% CI, -63.61 to 0.62; p=0.052). Conclusion: Our results suggest that CAPD might be more helpful than APD for preserving RRF during the first year of dialysis therapy, although there was no significant difference in the 1-year rate of decline of RRF between the two APD modalities.